Detalhe da pesquisa
1.
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.
N Engl J Med
; 384(1): 20-30, 2021 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33332779
2.
Time to clinically significant visual acuity gains after ranibizumab treatment for retinal vein occlusion: BRAVO and CRUISE trials.
Ophthalmology
; 121(5): 1059-66, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24424249
3.
Monthly versus as-needed ranibizumab injections in patients with retinal vein occlusion: the SHORE study.
Ophthalmology
; 121(12): 2432-42, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25060610
4.
Collateral vessel presence in branch and central retinal vein occlusions and their impact on visual acuity and anatomical gains: a retrospective analysis.
Retina
; 34(11): 2242-9, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25046394
5.
Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial.
Ophthalmology
; 119(4): 802-9, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22301066
6.
A pilot study of abacavir/lamivudine and raltegravir in antiretroviral-naïve HIV-1-infected patients: 48-week results of the SHIELD trial.
HIV Clin Trials
; 11(5): 260-9, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21126956
7.
Similar virologic and immunologic efficacy with fosamprenavir boosted with 100 mg or 200 mg of ritonavir in HIV-infected patients: results of the LESS trial.
HIV Clin Trials
; 11(5): 239-47, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21126954
8.
Changes in Manufacturing Processes of Biologic Therapies Can Alter the Immunogenicity Profile of the Product.
Clin Pharmacol Ther
; 107(4): 988-993, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31628764
9.
Clinically meaningful visual improvements and predictors of early vision gains with ranibizumab for diabetic macular oedema.
BMJ Open Ophthalmol
; 4(1): e000335, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31750396
10.
MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer.
Clin Cancer Res
; 25(10): 2988-2995, 2019 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30224341
11.
Once-daily abacavir/lamivudine and ritonavir-boosted atazanavir for the treatment of HIV-1 infection in antiretroviral-naïve patients: a 48-week pilot study.
HIV Clin Trials
; 9(3): 152-63, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18547902
12.
The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial.
Lancet
; 368(9534): 476-82, 2006 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-16890834
13.
Once-daily abacavir/lamivudine/zidovudine plus tenofovir for the treatment of HIV-1 infection in antiretroviral-naïve subjects: a 48-week pilot study.
HIV Clin Trials
; 7(6): 324-33, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-17208898
14.
Simplified maintenance therapy with abacavir/lamivudine and atazanavir after discontinuation of ritonavir.
HIV Clin Trials
; 11(3): 170-3, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20736153
15.
Primary tumor location as a prognostic factor in metastatic colorectal cancer.
J Natl Cancer Inst
; 107(3)2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25713148
16.
Asymptomatic hyperlactataemia: predictive value, natural history and correlates.
Antivir Ther
; 9(2): 205-12, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15134182
17.
Compact quadruple therapy with the lamivudine/zidovudine combination tablet plus abacavir and efavirenz, followed by the lamivudine/zidovudine/abacavir triple nucleoside tablet plus efavirenz in treatment-naïve HIV-infected adults.
HIV Clin Trials
; 4(4): 231-43, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-12916008
18.
Impact of comorbidities and drug therapy on development of renal impairment in a predominantly African American and Hispanic HIV clinic population.
HIV AIDS (Auckl)
; 3: 1-8, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22096402
19.
Modulation of K65R selection by zidovudine inclusion: analysis of HIV resistance selection in subjects with virologic failure receiving once-daily abacavir/lamivudine/zidovudine and tenofovir DF (study COL40263).
AIDS Res Hum Retroviruses
; 25(7): 665-72, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19563238
20.
Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment.
AIDS
; 23(12): 1547-56, 2009 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-19542866